2006
DOI: 10.1111/j.1462-5822.2006.00756.x
|View full text |Cite
|
Sign up to set email alerts
|

CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
122
1
3

Year Published

2007
2007
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 123 publications
(132 citation statements)
references
References 29 publications
6
122
1
3
Order By: Relevance
“…Notably, it has been established that OxPAPC binds to serum accessory proteins such as LBP and CD14 and competitively inhibits the binding of LPS to these proteins (17). Likewise, it has been shown that both di-acyl and tri-acyl bacterial lipopeptides bind to CD14 and LBP (35,47) and that CD14 and LBP are required for enhanced cellular sensitivity to bacterial lipopeptides (32,34). Thus, it is likely that the established binding of OxPAPC to CD14 and LBP (17) also contributes to the inhibition of cellular responsiveness to lipopeptides via TLR2.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Notably, it has been established that OxPAPC binds to serum accessory proteins such as LBP and CD14 and competitively inhibits the binding of LPS to these proteins (17). Likewise, it has been shown that both di-acyl and tri-acyl bacterial lipopeptides bind to CD14 and LBP (35,47) and that CD14 and LBP are required for enhanced cellular sensitivity to bacterial lipopeptides (32,34). Thus, it is likely that the established binding of OxPAPC to CD14 and LBP (17) also contributes to the inhibition of cellular responsiveness to lipopeptides via TLR2.…”
Section: Discussionmentioning
confidence: 99%
“…7A). Because OxPAPC has been shown to bind to CD14 (17) and sCD14 has been shown to play a role in lipopeptide signaling (32,34,35), we examined whether supplementation of the culture medium with recombinant sCD14 alone may also reverse OxPAPC-induced inhibition of TLR2 signaling. Consistent with a role for this protein, OxPAPC inhibition of Pam 3 CSK 4 signaling was reversed by sCD14 supplementation in a dose-dependent fashion (Fig.…”
Section: Oxpapc Inhibits Signaling Via Tlr2 and Tlr4 But Not Othermentioning
confidence: 99%
“…CD14 and vitronectin facilitate the transfer of lipopeptides to the TLR2 receptor complex (19,20). It therefore appears that multiple accessory proteins are required by both TLR2 and TLR4 for optimum responses to lipid-based agonists.…”
Section: Discussionmentioning
confidence: 99%
“…1 ligands of >TLRs require presentation via a coreceptor. The coreceptor CD14 has been implicated in facilitating TLR-mediated responses to bacterial lipopeptides by enhancing the physical proximity of the ligand to the TLR heterodimers, without binding directly to the receptor complex (30)(31)(32). However, as demonstrated above, soluble CD14 did not inhibit cell migration in our system (Supplemental Fig.…”
Section: Cd16mentioning
confidence: 61%